{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:19:26Z","timestamp":1793366366417,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":91,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101198","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:57:40Z","timestamp":1775231860000},"page":"101198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["miR-155 and the orchestration of cell-death evasion and chemoresistance in cancer: Isoform-specific mechanisms and therapeutic opportunities"],"prefix":"10.1016","volume":"47","author":[{"given":"Saeb Younis","family":"Abdul-Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkareem","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bethanney","family":"Janney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjant","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitora","family":"Tilyavova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder Naji","family":"Sameer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasim M.","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohaned","family":"Adil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101198_bib0001","series-title":"Exosomes and MicroRNAs in Biomedical Science","first-page":"1","article-title":"MicroRNA biogenesis and function","author":"Mirzaei","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101198_bib0002","first-page":"13","article-title":"Exosomal microRNA profiling","author":"Rahimian","year":"2022","journal-title":"MicroRNA Profiling: Methods And Protocols"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0003","first-page":"651","article-title":"Recent molecular genetic explorations of Caenorhabditis elegans microRNAs","volume":"209","author":"Ambros","year":"2018","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12935-023-03022-5","article-title":"MiRNA-related metastasis in oral cancer: moving and shaking","volume":"23","author":"Eslami","year":"2023","journal-title":"Cancer Cell International"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","article-title":"Exosomal miRNAs: the tumor's trojan horse in selective metastasis","volume":"23","author":"Bayat","year":"2024","journal-title":"Molecular Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0006","series-title":"Cell Biology and Translational medicine, Volume 17: Stem Cells in Tissue differentiation, Regulation and Disease","first-page":"97","article-title":"Virus, exosome, and MicroRNA: new insights into autophagy","author":"Sadri Nahand","year":"2022"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0007","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12950-024-00417-7","article-title":"Regulatory role of microRNAs in virus-mediated inflammation","volume":"21","author":"Bannazadeh Baghi","year":"2024","journal-title":"Journal of Inflammation"},{"key":"10.1016\/j.ctarc.2026.101198_bib0008","series-title":"MicroRNAs in cancer. Exosomes and MicroRNAs in Biomedical Science","first-page":"11","author":"Mirzaei","year":"2022"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0009","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12935-025-03786-y","article-title":"To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death","volume":"25","author":"Taghizadieh","year":"2025","journal-title":"Cancer Cell International"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101198_bib0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","article-title":"Cancer-associated miRNAs and their therapeutic potential","volume":"66","author":"Inoue","year":"2021","journal-title":"Journal of Human Genetics"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101198_bib0011","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/cc.7.17.6597","article-title":"Mechanisms of microRNA deregulation in human cancer","volume":"7","author":"Deng","year":"2008","journal-title":"Cell cycle (Georget. Tex)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0012","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12935-023-03022-5","article-title":"MiRNA-related metastasis in oral cancer: moving and shaking","volume":"23","author":"Eslami","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101198_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8874854","article-title":"MicroRNA-155: regulation of immune cells in sepsis","volume":"2021","author":"Chen","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.ctarc.2026.101198_bib0014","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","article-title":"MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis","volume":"8","author":"Alivernini","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ctarc.2026.101198_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154789","article-title":"MicroRNA-155 and cancer metastasis: regulation of invasion, migration, and epithelial-to-mesenchymal transition","volume":"250","author":"Moutabian","year":"2023","journal-title":"Pathol. - Res. Pract."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4149\/neo_2014_032","article-title":"miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies","volume":"61","author":"Jurkovicova","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.ctarc.2026.101198_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708765","article-title":"Tumor suppressor miRNA in cancer cells and the Tumor microenvironment: mechanism of deregulation and clinical implications","volume":"11","author":"Otmani","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0018","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12943-024-02060-5","article-title":"Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer","volume":"23","author":"Dogra","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153405","article-title":"MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer","volume":"220","author":"Li","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0020","first-page":"326","article-title":"Paclitaxel\u2011resistant gastric cancer MGC\u2011803 cells promote epithelial\u2011to\u2011mesenchymal transition and chemoresistance in paclitaxel\u2011sensitive cells via exosomal delivery of miR\u2011155\u20115p","volume":"54","author":"Wang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101198_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116412","article-title":"The role of miR-155 in urologic malignancies","volume":"174","author":"Shen","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0022","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s40001-025-02618-z","article-title":"Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy","volume":"30","author":"Hussain","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072245","article-title":"The role of miR-155 in nutrition: modulating cancer-associated inflammation","volume":"13","author":"Zanoaga","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ctarc.2026.101198_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140134","article-title":"MiRNA-155: a double-edged sword in colorectal cancer progression and drug resistance mechanisms","volume":"299","author":"Hussen","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101198_bib0025","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4161\/15384047.2014.955442","article-title":"miRNA biogenesis: biological impact in the development of cancer","volume":"15","author":"Romero-Cordoba","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101198_bib0026","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10529-014-1540-3","article-title":"miR-155 regulates the proliferation and cell cycle of colorectal carcinoma cells by targeting E2F2","volume":"36","author":"Li","year":"2014","journal-title":"Biotechnol. Lett."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101198_bib0027","first-page":"2115","article-title":"MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer","volume":"7","author":"Shen","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ctarc.2026.101198_bib0028","article-title":"MicroRNA-155-5p contributes to 5-fluorouracil resistance through down-regulating TP53INP1 in oral squamous cell carcinoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0029","first-page":"4781","article-title":"MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol Lett"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101198_bib0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/cgt.2012.60","article-title":"MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression","volume":"19","author":"Zang","year":"2012","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101198_bib0031","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1158\/1078-0432.CCR-16-1025","article-title":"Combining Anti-Mir-155 with chemotherapy for the treatment of lung cancers","volume":"23","author":"Van Roosbroeck","year":"2017","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101198_bib0032","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3324\/haematol.2019.227579","article-title":"Targeting CD47\/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma","volume":"105","author":"Rastgoo","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ctarc.2026.101198_bib0033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gene.2019.02.066","article-title":"MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer","volume":"700","author":"Zhang","year":"2019","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0034","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1007\/s13277-016-4804-9","article-title":"MicroRNA-155 promotes apoptosis in SKOV3, A2780, and primary cultured ovarian cancer cells","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour biol.: j. Int. Soc. Oncodevelopmental Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101198_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140134","article-title":"MiRNA-155: a double-edged sword in colorectal cancer progression and drug resistance mechanisms","volume":"299","author":"Hussen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101198_bib0036","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220070","article-title":"miR-155-3p: processing by-product or rising star in immunity and cancer?","volume":"12","author":"Dawson","year":"2022","journal-title":"Open Biol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0037","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. rev. Drug discov."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0038","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ctarc.2026.101198_bib0039","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biocel.2018.04.005","article-title":"MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer","volume":"99","author":"Wang","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4149\/neo_2020_200106N17","article-title":"miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy","volume":"68","author":"Yu","year":"2021","journal-title":"Neoplasma"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0041","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1582-4934.2010.01104.x","article-title":"MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1","volume":"15","author":"Liu","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114248","article-title":"Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma","volume":"442","author":"Park","year":"2024","journal-title":"Exp Cell Res"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101198_bib0043","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.molonc.2016.08.005","article-title":"Autophagy inhibition upregulates CD4(+) tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation","volume":"10","author":"Zarogoulidis","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101198_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144224","article-title":"TNF-\u03b1\/miR-155 axis induces the transformation of osteosarcoma cancer stem cells independent of TP53INP1","volume":"726","author":"Yao","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.ctarc.2026.101198_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2021.100855","article-title":"Inhibition of miR-155-5p in non-small cell lung cancer, a potential target for induction of autophagy","volume":"28","author":"Moayedi","year":"2021","journal-title":"Meta Gene"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0046","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s10142-023-01186-x","article-title":"Andrographis modulates cisplatin resistance in lung cancer via miR-155-5p\/SIRT1 axis","volume":"23","author":"Pang","year":"2023","journal-title":"Funct. Integr. Genom."},{"issue":"7-8","key":"10.1016\/j.ctarc.2026.101198_bib0047","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/02652048.2021.1979673","article-title":"Hesperidin-loaded nanoemulsions improve cytotoxicity, induce apoptosis, and downregulate miR-21 and miR-155 expression in MCF-7","volume":"38","author":"Magura","year":"2021","journal-title":"J. Microencapsul."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101198_bib0048","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1021\/acs.jafc.8b06665","article-title":"(-)-Epigallocatechin gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5-FU by inhibiting GRP78\/NF-\u03bab\/miR-155-5p\/MDR1 pathway","volume":"67","author":"La","year":"2019","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0049","doi-asserted-by":"crossref","first-page":"511","DOI":"10.21037\/tcr.2017.06.20","article-title":"A novel Camptothecin analogue inhibits colon cancer development and downregulates the expression of miR-155 in vivo and in vitro","volume":"6","author":"Lin","year":"2017","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbrc.2012.09.126","article-title":"Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155","volume":"428","author":"Pu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0051","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cas.13177","article-title":"MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K\/Akt pathway","volume":"108","author":"Fu","year":"2017","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0052","doi-asserted-by":"crossref","first-page":"228","DOI":"10.18632\/aging.103669","article-title":"Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis","volume":"13","author":"Xu","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.ctarc.2026.101198_bib0053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12688\/wellcomeopenres.15065.2","article-title":"Transient up-regulation of miR-155-3p by lipopolysaccharide in primary human monocyte-derived macrophages results in RISC incorporation but does not alter TNF expression","volume":"4","author":"Simmonds","year":"2019","journal-title":"Wellcome Open Res."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101198_bib0054","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.220070","article-title":"miR-155-3p: processing by-product or rising star in immunity and cancer?","volume":"12","author":"Dawson","year":"2022","journal-title":"Open biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13046-016-0371-6","article-title":"MicroRNA-155-3p promotes hepatocellular carcinoma formation by suppressing FBXW7 expression","volume":"35","author":"Tang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101198_bib0056","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1055-9965.EPI-12-0173","article-title":"The oncogenic role of miR-155 in breast cancer","volume":"21","author":"Mattiske","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev.: Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0057","first-page":"1043","article-title":"NT21MP negatively regulates paclitaxel-resistant cells by targeting miR\u2011155\u20113p and miR\u2011155-5p via the CXCR4 pathway in breast cancer","volume":"53","author":"Wang","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0058","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12906-023-04168-5","article-title":"Milk thistle nano-micelle formulation promotes cell cycle arrest and apoptosis in hepatocellular carcinoma cells through modulating miR-155-3p \/SOCS2 \/PHLDA1 signaling axis","volume":"23","author":"Rahnama","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101198_bib0059","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1111\/jcmm.15192","article-title":"MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1","volume":"24","author":"Chen","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ctarc.2026.101198_bib0060","series-title":"Targeting Apoptosis to Overcome Chemotherapy Resistance","first-page":"163","author":"Dogan","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101198_bib0061","series-title":"Advances in Protein Chemistry and Structural Biology. 126","first-page":"91","article-title":"Chapter four - alternative approaches to overcome chemoresistance to apoptosis in cancer","author":"Balaji","year":"2021"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101198_bib0062","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11912-022-01199-y","article-title":"Targeting apoptosis in cancer","volume":"24","author":"Singh","year":"2022","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101198_bib0063","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101198_bib0064","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.semcancer.2014.05.002","article-title":"Targeting apoptosis for anticancer therapy","volume":"31","author":"Fulda","year":"2015","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0065","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0066","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101198_bib0067","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","article-title":"Cell death pathways and viruses: role of microRNAs","volume":"24","author":"Sadri Nahand","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101198_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105730","article-title":"Oncogenic viruses and chemoresistance: what do we know?","volume":"170","author":"Sadri Nahand","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ctarc.2026.101198_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154653","article-title":"Human papillomavirus maybe is a critical player in the regulation of chemoresistance related factors (P53, Rb, TWIST, Bcl-2, Bcl-XL, c-IAP2, cytochrome C, and caspase 3) in breast cancer","volume":"248","author":"Haghighi","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101198_bib0070","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ejca.2005.02.018","article-title":"Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: potential targets for apoptosis induction","volume":"41","author":"Koornstra","year":"2005","journal-title":"Eur. j. cancer (Oxf. Engl.: 1990)"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0071","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"issue":"39","key":"10.1016\/j.ctarc.2026.101198_bib0072","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ctarc.2026.101198_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105179","article-title":"The P53\/microRNA network: a potential tumor suppressor with a role in anticancer therapy","volume":"160","author":"Sargolzaei","year":"2020","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101198_bib0074","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0075","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1074\/jbc.M111.285718","article-title":"miR-125b and miR-155 contribute to BCL2 repression and proliferation in response to CD40 ligand (CD154) in human leukemic B-cells","volume":"287","author":"Willimott","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0076","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00280-014-2651-1","article-title":"Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0077","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.21037\/tcr-2025-8","article-title":"The miR-155-5p\/FBXO11 axis inhibits the progression of gastric cancer via the mTOR pathway","volume":"14","author":"Yuan","year":"2025","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0078","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7150\/jca.54775","article-title":"Loss of MiR-155 sensitizes FLT3-ITD(+)AML to chemotherapy and FLT3 inhibitors via glycolysis blocking by targeting PIK3R1","volume":"14","author":"Wang","year":"2023","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0079","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06061-x","article-title":"miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells","volume":"7","author":"Gu","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101198_bib0080","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3109\/10428194.2012.659736","article-title":"Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1","volume":"53","author":"Kim","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ctarc.2026.101198_bib0081","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.omtn.2020.08.037","article-title":"circRNA circARNT2 suppressed the sensitivity of hepatocellular carcinoma cells to cisplatin by targeting the miR-155-5p\/PDK1 axis","volume":"23","author":"Li","year":"2021","journal-title":"Mol. ther. Nucleic acids"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101198_bib0082","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/leu.2014.344","article-title":"miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib","volume":"29","author":"Guinn","year":"2015","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0083","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-020-01229-y","article-title":"Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0084","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.omto.2020.05.002","article-title":"miR-155 accelerates the growth of Human liver cancer cells by activating CDK2 via targeting H3F3A","volume":"17","author":"Xin","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"29","key":"10.1016\/j.ctarc.2026.101198_bib0085","doi-asserted-by":"crossref","first-page":"47849","DOI":"10.18632\/oncotarget.18133","article-title":"Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155\/GATA3 axis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0086","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3892\/or.2012.1634","article-title":"Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis","volume":"27","author":"Zheng","year":"2012","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0087","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ijlh.13225","article-title":"LncRNA MEG3 contributes to drug resistance in acute myeloid leukemia by positively regulating ALG9 through sponging miR-155","volume":"42","author":"Yu","year":"2020","journal-title":"Int. j. lab. hematol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0088","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-4598-13-79","article-title":"MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia","volume":"13","author":"Palma","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153676","article-title":"Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression","volume":"228","author":"Yang","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ctarc.2026.101198_bib0090","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12935-017-0469-8","article-title":"miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3\u03b2-involved wnt\/\u03b2-catenin signaling","volume":"17","author":"Chen","year":"2017","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ctarc.2026.101198_bib0091","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2147\/CMAR.S225489","article-title":"LncRNA miR503HG regulates the drug resistance of recurrent cervical squamous cell carcinoma cells by regulating miR-155\/caspase-3","volume":"12","author":"Zhao","year":"2020","journal-title":"Cancer Manag Res"},{"issue":"18","key":"10.1016\/j.ctarc.2026.101198_bib0092","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","article-title":"FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in Glioma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer res."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101198_bib0093","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/cgt.2012.60","article-title":"MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression","volume":"19","author":"Zang","year":"2012","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0094","first-page":"1303","article-title":"Downregulation of miR-155 inhibits proliferation and enhances chemosensitivity to Temozolomide in glioma cells","volume":"10","author":"Meng","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1042\/CBI20100918","article-title":"Anti-miR-155 oligonucleotide enhances chemosensitivity of U251 cell to taxol by inducing apoptosis","volume":"36","author":"Meng","year":"2012","journal-title":"Cell Biol. Int."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0096","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/jcb.25073","article-title":"miR-155 regulates glioma cells invasion and chemosensitivity by p38 isforms In vitro","volume":"116","author":"Liu","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0097","first-page":"59","article-title":"Targeting miR\u2011155\u20115p and miR\u2011221\u20113p by peptide nucleic acids induces caspase\u20113 activation and apoptosis in temozolomide\u2011resistant T98G glioma cells","volume":"55","author":"Milani","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0098","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12935-021-01753-x","article-title":"CircTP63 promotes hepatocellular carcinoma progression by sponging miR-155-5p and upregulating ZBTB18","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0099","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.073","article-title":"Proliferation and apoptosis of B-cell lymphoma cells under targeted regulation of FOXO3 by miR-155","volume":"12","author":"Zheng","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/srep42339","article-title":"MicroRNA-155 controls exosome synthesis and promotes gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Mikamori","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101198_bib0101","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1166\/nnl.2020.3144","article-title":"Clinical significance of MicroRNA-155-regulated autophagy and apoptosis by targeting rictor\/fos in gastric cancer progression","volume":"12","author":"Chen","year":"2020","journal-title":"Nanosci. Nanotechnol. Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/auto.26534","article-title":"Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway","volume":"10","author":"Wan","year":"2014","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101198_bib0103","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.joca.2016.01.005","article-title":"MicroRNA-155 suppresses autophagy in chondrocytes by modulating expression of autophagy proteins","volume":"24","author":"D'Adamo","year":"2016","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ctarc.2026.101198_bib0104","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/5584_2022_715","article-title":"Virus, exosome, and MicroRNA: new insights into autophagy","volume":"1401","author":"J","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-024-09907-z","article-title":"Let's make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment","volume":"40","author":"Bayat","year":"2024","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0106","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3892\/etm.2014.1752","article-title":"miR-155 mediates drug resistance in osteosarcoma cells via inducing autophagy","volume":"8","author":"Chen","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101198_bib0107","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-20-0832","article-title":"A lncRNA TCL6-miR-155 interaction regulates the Src-Akt-EMT network to mediate kidney cancer progression and metastasis","volume":"81","author":"Kulkarni","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101198_bib0108","first-page":"135","article-title":"LIN28B-mediated PI3K\/AKT pathway activation promotes metastasis in colorectal cancer models","author":"Shin","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101198_bib0109","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.21037\/tcr-24-543","article-title":"MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR","volume":"13","author":"Guo","year":"2024","journal-title":"Transl. Cancer res."},{"key":"10.1016\/j.ctarc.2026.101198_bib0110","article-title":"Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0111","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-024-09907-z","article-title":"Let\u2019s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment","volume":"40","author":"Bayat","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ctarc.2026.101198_bib0112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-pathol-052016-100247","article-title":"Necroptosis: mechanisms and relevance to disease","volume":"12","author":"Galluzzi","year":"2017","journal-title":"Annu. Rev. Pathol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101198_bib0113","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1055-9965.EPI-12-0173","article-title":"The oncogenic role of miR-155 in breast cancer","volume":"21","author":"Mattiske","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"40","key":"10.1016\/j.ctarc.2026.101198_bib0114","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1038\/onc.2016.68","article-title":"Increased miR-155-5p and reduced miR-148a-3p contribute to the suppression of osteosarcoma cell death","volume":"35","author":"Bhattacharya","year":"2016","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101198_bib0115","doi-asserted-by":"crossref","DOI":"10.18632\/aging.103844","article-title":"Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p\/MLKL axis in chronic myeloid leukemia","volume":"12","author":"Huang","year":"2020","journal-title":"Aging"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101198_bib0116","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317711539","article-title":"Necroptosis in cancer: an angel or a demon?","volume":"39","author":"Wang","year":"2017","journal-title":"Tumor Biol."},{"issue":"35","key":"10.1016\/j.ctarc.2026.101198_bib0117","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034592","article-title":"MiR-155 enhances phagocytosis of alveolar macrophages through the mTORC2\/RhoA pathway","volume":"102","author":"Yang","year":"2023","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12967-021-03156-y","article-title":"microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82","volume":"20","author":"Song","year":"2022","journal-title":"J. transl. med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0119","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2012.03.013","article-title":"Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma","volume":"181","author":"Huang","year":"2012","journal-title":"Am. j. pathol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41419-021-03458-5","article-title":"Caspase 3\/GSDME-dependent pyroptosis contributes to chemotherapy drug-induced nephrotoxicity","volume":"12","author":"Shen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101198_bib0121","article-title":"The multifaceted roles of gasdermins in cancer biology and oncologic therapies","volume":"1876","author":"Sarri\u00f3","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0122","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6968641","article-title":"Resveratrol downregulates miR-155-5p to block the malignant behavior of gastric cancer cells","volume":"2022","author":"Su","year":"2022","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101198_bib0123","article-title":"The tumor microenvironment's gambit: exosomal pawns on the board of head and neck cancer","volume":"1879","author":"Mohamadi","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101198_bib0124","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04055-5","article-title":"Battlegrounds of treatment resistance: decoding the tumor microenvironment","author":"Bayat","year":"2025","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101198_bib0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-025-04105-1","article-title":"Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment","author":"Bayat","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101198_bib0126","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04209-5","article-title":"Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements","author":"Jallod","year":"2025","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101198_bib0127","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s13018-021-02793-9","article-title":"Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells","volume":"16","author":"Gao","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.ctarc.2026.101198_bib0128","first-page":"1","article-title":"Battlegrounds of treatment resistance: decoding the tumor microenvironment","author":"Bayat","year":"2025","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101198_bib0129","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s11033-018-4416-0","article-title":"Alleviating the progression of acute myeloid leukemia (AML) by sulforaphane through controlling miR-155 levels","volume":"45","author":"Koolivand","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ctarc.2026.101198_bib0130","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2018-99-119861","article-title":"Phase 1 trial of Cobomarsen, an inhibitor of Mir-155, in cutaneous T cell lymphoma","volume":"132","author":"Querfeld","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101198_bib0131","article-title":"MicroRNA155 in non-small cell lung cancer: a potential therapeutic target","author":"Wei","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101198_bib0132","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fonc.2020.01415","article-title":"Hsa-miR-155-5p up-regulation in breast cancer and its relevance for treatment with poly[ADP-Ribose] polymerase 1 (PARP-1) inhibitors","volume":"10","author":"Pasculli","year":"2020","journal-title":"Front. oncol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101198_bib0133","doi-asserted-by":"crossref","first-page":"933","DOI":"10.7150\/ijms.82216","article-title":"LncRNA MIR155HG overexpression promotes proliferation, migration, and chemoresistance in gastric cancer cells","volume":"20","author":"Lin","year":"2023","journal-title":"Int. j. Med. Sci."},{"key":"10.1016\/j.ctarc.2026.101198_bib0134","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25341-9","article-title":"Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers","volume":"12","author":"Mao","year":"2021","journal-title":"Nat. Commun."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101198_bib0135","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1158\/0008-5472.CAN-12-1400","article-title":"Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family","volume":"72","author":"Pouliot","year":"2012","journal-title":"Cancer Res."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:41:27Z","timestamp":1780918887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":135,"alternative-id":["S2468294226001097"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101198","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-155 and the orchestration of cell-death evasion and chemoresistance in cancer: Isoform-specific mechanisms and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101198"}}